Diabetes and Diabetic Uropathy (2017)
This symposium seeks to bring together multidisciplinary researchers for data/results and intellectual cross-fertilization for not only the study of diabetic uropathy, but the effects of diabetes on other represented systems as well.
- Medical Student
After completing this activity, partipants will be able to:
- To provide a broader multidisciplinary understanding of the overall impact of diabetes on the patient by and for investigators from different medical disciplines.
- To stimulate future research directions by cross-fertilization of insights from investigators of other organ systems affected by diabetes.
- To facilitate communication between researchers and clinicians regarding diabetic bladder dysfunction (DBD), including the establishment of a clinical definition of this condition.
- To update what is known about the basic pathophysiology of DBD and to identify gaps for future research.
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Following the workshop, and email will be sent to direct participants to claim CME credit.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational
- activity by the course/program director, editor, and/or Education Content Review Committee or its
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in
- procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
- 11.75 AMA PRA Category 1 Credit™
- 11.75 Non-Physician Participation